All Stories

  1. Acute strenuous exercise does not meaningfully influence lipoprotein(a)-based cardiovascular risk classification in endurance athletes
  2. Impaired Peripheral Oxygen Diffusion is the Primary Determinant of Exercise Intolerance in High-risk Older Breast Cancer Survivors
  3. Absolute and workload-indexed exercise blood pressure responses: associations with cardiac output, vascular resistance, and cardiorespiratory fitness in females
  4. From healthy to heart failure in 24 hours: defining the upper limit of exercise-induced cardiac fatigue
  5. Association of Self-reported Sports Volume and Discipline with Atrial Arrhythmia Prevalence in Middle-Aged Males
  6. High heart rate peaks from chest-strap recordings in athletes: Prevalence, characteristics, and clinical relevance
  7. Angina, Anomalous Coronaries, Surgical Correction, and Return to Olympic Cycling
  8. Differentiating Cardiac (Mal)adaptation in 2 Athletes With Bicuspid Aortic Valves
  9. Exercise blood pressure response does not differentiate endurance athletes with paroxysmal atrial fibrillation
  10. National Funding for Cardiac Arrest Research in Australia: An Analysis of Competitive Grant Schemes
  11. Electroanatomical Mapping May Identify Concealed Arrhythmogenic Cardiomyopathy in Endurance Athletes With Complex Ventricular Arrhythmias
  12. Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvement
  13. Exercise blood pressure relative to fitness and cardiovascular outcomes: the EXERTION study
  14. Moving From Eyeball Assessment to Quantification of the Right Ventricular “Hot Spot” in Arrhythmogenic Cardiomyopathy
  15. Arrhythmias and structural remodeling in lifelong and retired master endurance athletes
  16. Reduced PI3K(p110α) induces atrial myopathy, and PI3K-related lipids are dysregulated in athletes with atrial fibrillation
  17. “Letter to “Pathological contributors to organ damage and mortality in systemic sclerosis: A nationwide matched case-control study”: Author's Reply
  18. Maybe Valsalva, but please consider big hearts in middle-aged athletes as an explanation for atrial fibrillation prevalence
  19. Left atrioventricular ratio (LA:LV): using left ventricular size as the reference for identifying maladaptive left atrial remodelling
  20. Minimal extra-cardiac atherosclerosis present in young people with sudden cardiac death due to coronary artery disease
  21. Diagnostic accuracy of different exercise blood pressure metrics in identifying hypertension on 24-h ambulatory blood pressure monitoring in athletes
  22. Balancing Exercise Benefits Against Heartbeat Consumption in Elite Cyclists
  23. Mechanistic Insights Into Reduced Arrhythmia Prevalence in Female Endurance Athletes
  24. Similar But Different
  25. Pathological contributors to organ damage and mortality in systemic sclerosis: a nationwide matched case-control study
  26. Trends and differences in the rates of autopsy in the United States, 2003 to 2020: A nationwide analysis
  27. The term ‘athlete’s heart’ encapsulates both male and female athletic hearts if indexed correctly
  28. Exercise in Inherited Cardiomyopathies: Optimizing the Dose-Response Curve
  29. Atrial fibrillation in former world-class rowers: role of environmental and genetic factors
  30. Validation of magnetic resonance imaging-derived venous oxygen saturation and oxygen consumption measurements during exercise
  31. Cardiac arrest in the Australian Alps: A 20-year analysis
  32. Female endurance athletes: smaller hearts but similar relationship between ventricular size, fitness and fibrosis as male athletes
  33. Recommendations for cardiac screening and emergency action planning in youth football: a FIFA consensus statement
  34. Correction to: Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology
  35. Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology
  36. Cardiac arrest in Australia: a call to action
  37. Insights From a 20-Year Follow-Up of the First Heart Transplant Recipient to Complete an Ironman Triathlon
  38. Stepping up physical activity and fitness is needed for longevity
  39. Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities
  40. Location of Left Ventricular Outflow Tract Measurements for Stroke Volume Estimation With Echocardiography
  41. Genetics, Fitness, and Left Ventricular Remodelling: The Current State of Play
  42. Your Heart Can’t See What Sneakers You Are Wearing: Exercise Training Load in Endurance Athletes Is Inadequately Quantified in Sports Cardiology
  43. Editorial commentary: Exercise recommendations in hypertrophic cardiomyopathy shouldn't end at the recommendation
  44. Proposed minimum dataset for an athlete screening echocardiogram: the Standardised Transthoracic Echocardiogram Reporting in Athletes (STERA) protocol
  45. Preventing Allogeneic Stem Cell Transplant–Related Cardiovascular Dysfunction: ALLO-Active Trial
  46. RETRACTED AND REPLACED: Minimal extra-cardiac atherosclerosis present in young people with sudden cardiac death due to coronary artery disease
  47. The role of multi-modality imaging for the assessment of left atrium and left atrial appendage: a clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA) of the European Socie...
  48. Coronary atherosclerosis in athletes: emerging concepts and preventive strategies
  49. Cardiac arrhythmia assessment with patch electrocardiogram versus insertable cardiac monitor: a cohort study in endurance athletes with atrial fibrillation
  50. Small Heart Size and Premature Death in 366,484 Individuals With Normal Ejection Fraction
  51. Left ventricular size and heart failure: A cardiac MRI assessment of 38,129 individuals from the UK Biobank
  52. Comparison of 6-lead smartphone ECG and 12-lead ECG in athletes and a genetic heart disease population
  53. Ventricular arrhythmias in association with athletic cardiac remodelling
  54. A Call to Action to Improve Cardiac Arrest Outcomes: A Report From the National Summit for Cardiac Arrest
  55. Research Priorities for Atrial Fibrillation in Australia: A Statement From the Australian Cardiovascular Alliance Clinical Arrhythmia Theme
  56. Insights on blood pressure response to graded exercise in males and females across the age and fitness spectrum: reply
  57. Cardiorespiratory Fitness in Childhood Cancer Survivors: A Systematic Review and Meta-Analysis
  58. 2024 HRS expert consensus statement on arrhythmias in the athlete: Evaluation, treatment, and return to play
  59. Diversity of ICD-10 coding for sudden arrhythmic death syndrome is likely to create a spurious rise in cases under new ICD-11 nomenclature
  60. Lifelong physiology of a former marathon world-record holder: the pros and cons of extreme cardiac remodeling
  61. Physiological Insights From Asymptomatic Severe Valvular Disease in a Highly Trained Athlete
  62. Rationale and Design of the Australasian Registry of Screening ECGs in National Athletes Project
  63. Blood pressure response to graded bicycle exercise in males and females across the age and fitness spectrum
  64. Cancer Therapy and Exercise Intolerance: The Heart Is But a Part
  65. Histological evaluation of cardiac remodelling in equine athletes
  66. The Oxygen Cascade According to HFpEF Likelihood
  67. International Criteria for Reporting Study Quality for Sudden Cardiac Arrest/Death Tool
  68. 2024 CSANZ Position Statement on Indications, Assessment and Monitoring of Structural and Valvular Heart Disease With Transthoracic Echocardiography in Adults
  69. Physiological determinants of decreased peak leg oxygen uptake in chronic disease: a systematic review and meta-analysis
  70. Prevalence of atrial septal defects and patent foramen ovale in a cohort of sudden cardiac death patients undergoing autopsy
  71. Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis
  72. Response to: Regard to assessing agreement between two raters with kappa statistics
  73. The aortic paradox: a nationwide analysis of 523 994 individual echocardiograms exploring fatal aortic dissection
  74. Outrunning the grim reaper: longevity of the first 200 sub-4 min mile male runners
  75. Characterizing the influence of cardiorespiratory fitness on left atrial size and function in the general population
  76. Integrating Cardio-Oncology Across the Research Pipeline, Policy, and Practice in Australia—An Australian Cardiovascular Alliance Perspective
  77. Reduced Ejection Fraction in Elite Endurance Athletes: Clinical and Genetic Overlap With Dilated Cardiomyopathy
  78. Sex disparities in bystander defibrillation for out-of-hospital cardiac arrest
  79. Toxicology Screening in Sports-Related Sudden Cardiac Death
  80. Determinants of Impaired Peak Oxygen Uptake in Breast Cancer Survivors: JACC: CardioOncology Primer
  81. Contribution of Left Ventricular Diastolic Dysfunction to Survival and Breathlessness in Systemic Sclerosis–Associated Interstitial Lung Disease
  82. The challenge of risk stratification in hypertrophic cardiomyopathy: Clinical, genetic and imaging insights from a quaternary referral centre
  83. Lessons learnt in the first year of an Australian pediatric cardio oncology clinic
  84. Clinical outcomes of 10 years of cardiac screening in elite New Zealand athletes
  85. Prevalence of Multiple Causes of Death Within Young and Middle-Aged People Experiencing Sudden Cardiac Arrest
  86. Resuscitation of people with a do-not-resuscitate order: When does it happen and what are the outcomes?
  87. A Review on the Role of Exercise Training to Prevent a Decline in Cardiorespiratory Fitness and Cardiac Function in Breast Cancer Survivors
  88. Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation
  89. Effect of Exercise Training on Peak Aerobic Power After Heart Transplantation: A Brief Review
  90. Epidemiology of pediatric out-of-hospital cardiac arrest compared with adults
  91. Understanding Exercise Capacity: From Elite Athlete to HFpEF
  92. Ms-represented: strategies to increase female representation in sports cardiology research
  93. Extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest in Australia: a narrative review
  94. A two-point strategy to clarify prognosis in >80 year olds experiencing out of hospital cardiac arrest
  95. Influence of exercise training on the left atrium: implications for atrial fibrillation, heart failure, and stroke
  96. Prevalence of illicit drug use in young patients with sudden cardiac death
  97. Sudden cardiac death, arrhythmias and abnormal electrocardiography in systemic sclerosis: A systematic review and meta-analysis
  98. Multidisciplinary team discussion: the emerging gold standard for management of cardiopulmonary complications of connective tissue disease
  99. Associations between postrace atrial fibrillation and measures of performance, racing history and airway disease in horses
  100. Measurement of Stroke Volume With Echocardiography Compared to Gold Standard Cardiac Magnetic Resonance Imaging: An Observational Study
  101. Reply
  102. Semiautomatic Training Load Determination in Endurance Athletes
  103. The New South Wales Sudden Cardiac Arrest Registry: A Data Linkage Cohort Study
  104. Vascular Aging Is Accelerated in Hematological Cancer Survivors Who Undergo Allogeneic Stem Cell Transplant
  105. Sudden Cardiac Death in People With Schizophrenia
  106. Exercise-induced myocardial T1 increase and right ventricular dysfunction in recreational cyclists: a CMR study
  107. New-onset atrial fibrillation prediction: the HARMS2-AF risk score
  108. Return to play after myocarditis: time to abandon the one-size-fits-all approach?
  109. Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction
  110. Too Little of a Good Thing
  111. Athlete's Heart: A Cardiovascular Step-By-Step Multimodality Approach
  112. No Association Between Out-of-Hospital Cardiac Arrest and COVID-19 Vaccination
  113. A systematic review of global autopsy rates in all-cause mortality and young sudden death
  114. Declining Recognition of Chest Pain as a Cardiac Symptom Should Act as a Shot in The Arm
  115. Effects of training adaption in endurance athletes with atrial fibrillation: protocol for a multicentre randomised controlled trial
  116. Lifelong endurance exercise and its relation with coronary atherosclerosis
  117. Cardioprotection Using Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy
  118. Exercise-Induced Cardiac Remodeling and Atrial Fibrillation in Female Endurance Athletes
  119. Exercise for the Prevention of Anthracycline-Induced Functional Disability and Cardiac Dysfunction: The BREXIT Study
  120. Reduced cardiovascular reserve capacity in long-term allogeneic stem cell transplant survivors
  121. Disease specific determinants of cardiopulmonary fitness in systemic sclerosis
  122. In a large primary care dataset, the CHA₂DS₂-VASc score leads to almost universal recommendation for anticoagulation treatment in those aged ≥65 years with atrial fibrillation
  123. Aerosol Generation During High Intensity Exercise—Implications for COVID-19 Transmission
  124. Rapid cardiovascular aging following allogeneic hematopoietic cell transplantation for hematological malignancy
  125. Cardio-Oncology Recommendations for Pediatric Oncology Patients
  126. Late Afternoon Vigorous Exercise Increases Postmeal but Not Overnight Hypoglycemia in Adults with Type 1 Diabetes Managed with Automated Insulin Delivery
  127. Dynamic aspects of ventricular interaction during exercise in HFpEF and in pre‐capillary pulmonary hypertension
  128. Relating QRS voltages to left ventricular mass and body composition in elite endurance athletes
  129. The flatlining of cardiac arrest survival: can we revive the upward trend?
  130. The clinical implications of left ventricular diastolic dysfunction in systemic sclerosis
  131. Clinical and Pathologic Features of Out-of-Hospital Cardiac Arrest in Pregnancy
  132. Factors predicting cardiac arrest in acute coronary syndrome patients under 50: A state-wide angiographic and forensic evaluation of outcomes
  133. The Athlete’s Heart—Challenges and Controversies
  134. Type-2 Diabetes and the Clinical Importance of Exaggerated Exercise Blood Pressure
  135. Three-dimensional echocardiography of the athlete’s heart: a comparison with cardiac magnetic resonance imaging
  136. Inconsistent discharge diagnoses for young cardiac arrest episodes: insights from a statewide registry
  137. Analysis of athlete QT intervals by age: Fridericia and Hodges heart rate corrections outperform Bazett for athlete ECG screening
  138. Determinants of oxygen utilization in breast cancer: Similarities between heart failure with preserved ejection fraction
  139. Heart Failure With Preserved Ejection Fraction as an Exercise Deficiency Syndrome
  140. Obesity in young sudden cardiac death: Rates, clinical features, and insights into people with body mass index >50kg/m2
  141. Reduced death rates of elite Australian Rules footballers compared to age-matched general population
  142. Why Me? The Rise of Patients Without Traditional Cardiovascular Risk Factors
  143. Causes, circumstances, and potential preventability of cardiac arrest in the young: insights from a state-wide clinical and forensic registry
  144. Sudden cardiac death related to physical exercise in the young: a nationwide cohort study of Australia
  145. Preventing the adverse cardiovascular consequences of allogeneic stem cell transplantation with a multi-faceted exercise intervention: the ALLO-Active trial protocol
  146. Soldiers’ Heart: A Prospective Study of Cardiac Remodeling in Soldiers Undergoing Progressive Intensity Exercise Training
  147. Anabolic steroid misuse is an important reversible cause of cardiomyopathy: a case report
  148. Prevalence of Coronary Artery Anomalies in Young and Middle-Aged Sudden Cardiac Death Victims (from a Prospective State-Wide Registry)
  149. Return to exercise post-COVID-19 infection: A pragmatic approach in mid-2022
  150. Diastolic flow in the left ventricular outflow tract – A normal physiological and underappreciated echocardiographic finding
  151. Higher rates but similar causes of young out‐of‐hospital cardiac arrest in rural Australian patients
  152. The Impact of Ethnicity on Athlete ECG Interpretation: A Systematic Review
  153. On the characterization of athlete’s heart using 3D echocardiography
  154. Predictors and outcomes of in-hospital referrals for forensic investigation after young sudden cardiac death
  155. Risk Factors for Exercise-Associated Sudden Cardiac Death in Thoroughbred Racehorses
  156. Tackling an unmet need in sports cardiology: understanding exercise-induced cardiac remodelling and its clinical consequences
  157. Using magnetic resonance imaging to map the hidden burden of muscle involvement in systemic sclerosis
  158. Arrhythmogenic Right Ventricular Cardiomyopathy
  159. Diverse stakeholder engagement at the heart of co-designing cardiac arrest care
  160. Fit, Female or Fifty–Is Cardiac Rehabilitation “Fit” for Purpose for All? A Systematic Review and Meta-Analysis With Meta-Regression
  161. Use of a smartphone electrocardiogram to diagnose arrhythmias during exercise in athletes: a case series
  162. Impaired biventricular contractile reserve in patients with diastolic dysfunction: insights from exercise stress echocardiography
  163. The dysfunctional right ventricle: the importance of multi-modality imaging
  164. Postmortem Interrogation of Cardiac Implantable Electronic Devices
  165. Rationale and design of the PROspective ATHletic Heart (Pro@Heart) study: long-term assessment of the determinants of cardiac remodelling and its clinical consequences in endurance athletes
  166. A Comprehensive Approach to Managing Methamphetamine-Associated Cardiomyopathy
  167. Myocardial fibrosis and arrhythmic burden in systemic sclerosis
  168. Intracoronary IgG4-related disease as an unusual cause of sudden cardiac arrest: a case series
  169. Arrhythmogenic Right Ventricular Cardiomyopathy With Right Ventricular Thrombus Found Incidentally on a Trauma CT Scan
  170. Disease Specific Determinants of Cardiopulmonary Fitness in Systemic Sclerosis
  171. Response by Howden et al to Letter Regarding Article, “Oxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension”
  172. Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study
  173. A Randomized Crossover Trial Comparing Glucose Control During Moderate-Intensity, High-Intensity, and Resistance Exercise With Hybrid Closed-Loop Insulin Delivery While Profiling Potential Additional Signals in Adults With Type 1 Diabetes
  174. Athletes with mild COVID-19 illness demonstrate subtle imaging abnormalities without exercise impairment or arrhythmias
  175. Cardiorespiratory Fitness, Workload, and the Blood Pressure Response to Exercise Testing
  176. Multiday cycles of heart rate are associated with seizure likelihood: An observational cohort study
  177. Sudden Cardiac Death in Systemic Sclerosis: Diagnostics to Assess Risk and Inform Management
  178. Right ventricular and cyclic guanosine monophosphate signalling abnormalities in stages B and C of heart failure with preserved ejection fraction
  179. First Randomized Controlled Trial of Hybrid Closed Loop Versus Multiple Daily Injections or Insulin Pump Using Self-Monitoring of Blood Glucose in Free-Living Adults with Type 1 Diabetes Undertaking Exercise
  180. Prevention of Pathological Atrial Remodeling and Atrial Fibrillation
  181. The economic impact of sudden cardiac arrest
  182. Exercise oscillatory ventilation during autonomic blockade in young athletes and healthy controls
  183. Oxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension
  184. Comparison between a 6‑lead smartphone ECG and 12‑lead ECG in athletes
  185. The End Unexplained Cardiac Death (EndUCD) Registry for Young Australian Sudden Cardiac Arrest
  186. Feasibility of semi-recumbent bicycle exercise Doppler echocardiography for the evaluation of the right heart and pulmonary circulation unit in different clinical conditions: the RIGHT heart international NETwork (RIGHT-NET)
  187. Athletes with valvular heart disease and competitive sports: a position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology
  188. Endurance exercise and the risk of cardiovascular pathology in men: a comparison between lifelong and late-onset endurance training and a non-athletic lifestyle - rationale and design of the Master@Heart study, a prospective cohort trial
  189. Response to Sanchis-Gomar et al. ‘Atrial fibrillation in athletes and non-athletes: evidence of different causative mechanisms’
  190. Optimal Detection of Cardiac Sequelae
  191. The effect of posture on maximal oxygen uptake in active healthy individuals
  192. Prescribing Exercise in Early-Stage Breast Cancer During Chemotherapy: A Simple Periodized Approach to Align With the Cyclic Phases of Chemotherapy
  193. Traditional markers of cardiac toxicity fail to detect marked reductions in cardiorespiratory fitness among cancer patients undergoing anti-cancer treatment
  194. The Australia and New Zealand Cardio‐Oncology Registry: evaluation of chemotherapy‐related cardiotoxicity in a national cohort of paediatric cancer patients
  195. Exercise-Induced Arrhythmogenic (Right Ventricular) Cardiomyopathy Is Real…if you Consider it
  196. Predicting Left Ventricular Mass Using ECG, Demographic and DXA Features
  197. Acute glycaemic management before, during and after exercise for cardiac rehabilitation participants with diabetes mellitus: a joint statement of the British and Canadian Associations of Cardiovascular Prevention and Rehabilitation, the International C...
  198. Proof that exercise works, now it’s time for optimizing delivery to our patients with pulmonary hypertension
  199. Is the healthy respiratory system built just right, overbuilt, or underbuilt to meet the demands imposed by exercise?
  200. Mind the gap: Knowledge deficits in evaluating young sudden cardiac death
  201. Persistent Troponin Elevation in Left-Dominant Arrhythmogenic Cardiomyopathy
  202. Screening of Potential Cardiac Involvement in Competitive Athletes Recovering From COVID-19
  203. Multiday cycles of heart rate are associated with seizure likelihood
  204. Can post-mortem coronary artery calcium scores aid diagnosis in young sudden death?
  205. Smoke but no fire: increased myocardial infarction with normal coronary arteries in the Australian bushfires?
  206. Reassuring News for Athletes With Atrial Fibrillation, But Perhaps Not All Athletes
  207. Measuring atrial stasis during sinus rhythm in patients with paroxysmal atrial fibrillation using 4 Dimensional flow imaging
  208. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
  209. The effect of exercise training on cardiometabolic health in men with prostate cancer receiving androgen deprivation therapy: a systematic review and meta-analysis
  210. Differing mechanisms of atrial fibrillation in athletes and non-athletes: alterations in atrial structure and function
  211. Helping patients to help themselves: informing individuals predisposed to arrhythmogenic cardiomyopathy
  212. Exercise as a diagnostic and therapeutic tool for preventing cardiovascular morbidity in breast cancer patients– the BReast cancer EXercise InTervention (BREXIT) trial protocol
  213. Prospective long-term follow-up analysis of the cardiovascular system in marathon runners: study design of the Pro-MagIC study
  214. Audit of a cardiac screening policy for elite Australian cricketers
  215. Left Ventricular Fibrosis in Middle-Age Athletes and Physically Active Adults
  216. Left ventricular remodeling in elite and sub‐elite road cyclists
  217. Exercise and Arrhythmogenic Right Ventricular Cardiomyopathy
  218. Reduced Exercise Capacity in Diabetes Mellitus Is Not Associated with Impaired Deformation or Twist
  219. The Utility of Cardiac Reserve for the Early Detection of Cancer Treatment-Related Cardiac Dysfunction: A Comprehensive Overview
  220. Cardiac screening of athletes: consensus needed for clinicians on indications for follow-up echocardiography testing
  221. Cardiovascular Screening of Elite Athletes by Sporting Organizations in Australia: A Survey of Chief Medical Officers
  222. Fears of a Big Bang for Rugby Players, Urgent Validation Required
  223. Association between physical activity and risk of incident arrhythmias in 402 406 individuals: evidence from the UK Biobank cohort
  224. Multiday Cycles of Heart Rate Modulate Seizure Likelihood at Daily, Weekly and Monthly Timescales: An Observational Cohort Study
  225. Exercise cardiovascular magnetic resonance: development, current utility and future applications
  226. Exercise cardiovascular magnetic resonance reveals reduced cardiac reserve in pediatric cancer survivors with impaired cardiopulmonary fitness
  227. Cardiac arrest and sudden cardiac death registries: a systematic review of global coverage
  228. The Cardiac Society of Australia and New Zealand Position Statement on the Diagnosis and Management of Arrhythmogenic Right Ventricular Cardiomyopathy (2019 Update)
  229. Glucose and Counterregulatory Responses to Exercise in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia Using Closed-Loop Insulin Delivery: A Randomized Crossover Study
  230. Echocardiographic Assessment of Left Ventricular Remodeling in American Style Footballers
  231. Exercise Attenuates Cardiotoxicity of Anthracycline Chemotherapy Measured by Global Longitudinal Strain
  232. Right Ventricular Function
  233. Evaluation of Cardiac Function in Women With a History of Preeclampsia: A Systematic Review and Meta‐Analysis
  234. Pulmonary vascular remodelling in athletes: an anti-concept to be proved
  235. Atrial fibrillation in athletes: different but the same?
  236. Right ventricular strain rate during exercise accurately identifies male athletes with right ventricular arrhythmias
  237. ECG-based cardiac screening programs: Legal, ethical, and logistical considerations
  238. Brief recommendations for participation in leisure time or competitive sports in athletes–patients with coronary artery disease: Summary of a Position Statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC)
  239. Impaired Cardiac Reserve and Abnormal Vascular Load Limit Exercise Capacity in Chronic Thromboembolic Disease
  240. Sildenafil enhances central hemodynamic responses to exercise, but not V̇o2peak, in people with diabetes mellitus
  241. Brief recommendations for participation in competitive sports of athletes with arterial hypertension: Summary of a Position Statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC)
  242. Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association
  243. Heart Rate Reserve in Fontan Patients: Chronotropic Incompetence or Hemodynamic Limitation?
  244. Unsupervised respiratory signal extraction from ungated cardiac magnetic resonance imaging at rest and during exercise
  245. Persistent Impairment in Cardiopulmonary Fitness after Breast Cancer Chemotherapy
  246. Relation of Alcohol Consumption to Left Ventricular Fibrosis Using Cardiac Magnetic Resonance Imaging
  247. Right Ventricular Functional Reserve in Early-Stage Idiopathic Pulmonary Fibrosis
  248. Pulmonary Hypertension
  249. Determinants of exercise intolerance in breast cancer patients prior to anthracycline chemotherapy
  250. Sudden Death and Ventricular Arrhythmias in Athletes: Screening, De-Training and the Role of Catheter Ablation
  251. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC)
  252. Electrocardiographic Features Differentiating Arrhythmogenic Right Ventricular Cardiomyopathy From an Athlete’s Heart
  253. Measurement of microvascular function in patients presenting with thrombolysis for ST elevation myocardial infarction, and PCI for non-ST elevation myocardial infarction
  254. Regular Alcohol Consumption Is Associated With Impaired Atrial Mechanical Function in the Atrial Fibrillation Population
  255. Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients
  256. Misclassification of cricket in the American College of Cardiology (ACC) Task Force classification of sports
  257. Advanced Imaging to Phenotype Patients With a Systemic Right Ventricle
  258. Acute metabolic and cardiovascular effects of mirabegron in healthy individuals
  259. Drugs in Sport — A Change is Needed, but What?
  260. Sports Cardiology – A Bona Fide Sub-Specialty
  261. Sports Cardiology – Example Illustrative Cases
  262. Athlete’s Heart: Is the Morganroth Hypothesis Obsolete?
  263. Standing up to the cardiometabolic consequences of hematological cancers
  264. What May the Future Hold for Sports Cardiology?
  265. Recommendations for participation in competitive sports of athletes with arterial hypertension: a position statement from the sports cardiology section of the European Association of Preventive Cardiology (EAPC)
  266. Rationale and Design of the Strain Surveillance of Chemotherapy for Improving Cardiovascular Outcomes
  267. Single Versus Standard Multiview Assessment of Global Longitudinal Strain for the Diagnosis of Cardiotoxicity During Cancer Therapy
  268. Recommendations for participation in leisure time or competitive sports in athletes-patients with coronary artery disease: a position statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC)
  269. Right Heart-Pulmonary Circulation Unit in Cardiomyopathies and Storage Diseases
  270. The Right Heart International Network (RIGHT-NET)
  271. The ventricular residence time distribution derived from 4D flow particle tracing: a novel marker of myocardial dysfunction
  272. Atrial remodeling and ectopic burden in recreational athletes: Implications for risk of atrial fibrillation
  273. Exercise cardiac magnetic resonance to differentiate athlete’s heart from structural heart disease
  274. Exercise Blood Pressure Guidelines: Time to Re-evaluate What is Normal and Exaggerated?
  275. Exercise capacity in diabetes mellitus is predicted by activity status and cardiac size rather than cardiac function: a case control study
  276. Diagnosis and Significance of Pulmonary Microvascular Disease in Diabetes
  277. Mechanisms of the Improvement in Peak VO 2 With Exercise Training in Heart Failure With Reduced or Preserved Ejection Fraction
  278. The Right Ventricle: From Bench to Bedside
  279. Correction to: Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans
  280. New International Guidelines for the Interpretation of the Electrocardiograph in Athletes: a “Traffic Light” Tool for Maximising Diagnostic Specificity
  281. Atrial deformation in athletes with AF: chronic adverse remodelling or transient mechanical stunning?
  282. Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans
  283. Blood Pressure Response to Exercise and Cardiovascular Disease
  284. Chemotherapy-related cardiotoxicity: are Australian practitioners missing the point?
  285. A focus on the greatness of the lesser circulation - Spotlight Issue on the Right Ventricle
  286. State of the Art Review: Atrial Fibrillation in Athletes
  287. Point:Counterpoint
  288. Exercise and the right ventricle: a potential Achilles’ Heel
  289. Safety Concerns regarding article: Reliability and Validity of a Self-paced Cardiopulmonary Exercise Test in Post-MI Patients. L. A. Jenkins, A. Mauger, J. Fisher, J. Hopker. Int J Sports Med 2017; 38: 300–306.
  290. SASHA versus ShMOLLI: a comparison of T1 mapping methods in health and dilated cardiomyopathy at 3 T
  291. Closed-Loop Insulin Delivery for Adults with Type 1 Diabetes Undertaking High-Intensity Interval Exercise Versus Moderate-Intensity Exercise: A Randomized, Crossover Study
  292. Pulmonary Vascular Function During Exercise
  293. International criteria for electrocardiographic interpretation in athletes: Consensus statement
  294. International recommendations for electrocardiographic interpretation in athletes
  295. International Recommendations for Electrocardiographic Interpretation in Athletes
  296. Right ventricular and pulmonary vascular reserve in asymptomatic BMPR2 mutation carriers
  297. Cardiovascular Effects of Performance-Enhancing Drugs
  298. Right ventricular dilatation and function
  299. Increased Flow, Dam Walls, and Upstream Pressure
  300. Atrial volume and function during exercise in health and disease
  301. Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE
  302. Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE
  303. Pathophysiology of exercise intolerance in breast cancer survivors with preserved left ventricular ejection fraction
  304. Sports Cardiology
  305. A Modern Definition of the Athlete’s Heart—for Research and the Clinic
  306. Sports Cardiology: Comprehensive Clinical Care for Athletes and Highly Active Individuals
  307. Idiopathic Ventricular Tachycardia/Ventricular Fibrillation
  308. Letter by Heidbuchel et al Regarding Article, “Right and Left Ventricular Function and Mass in Male Elite Master Athletes: A Controlled Contrast-Enhanced Cardiovascular Magnetic Resonance Study”
  309. Stressing the right ventricular-pulmonary vascular unit: beyond pulmonary vascular resistance
  310. Effect of Experience and Training on the Concordance and Precision of Strain Measurements
  311. Acute effect of static exercise in patients with aortic regurgitation assessed by cardiovascular magnetic resonance: role of left ventricular remodelling
  312. Exercise-induced cardiac fatigue: the need for speed
  313. Insulin pump basal adjustment for exercise in type 1 diabetes: a randomised crossover study
  314. Accuracy of Echocardiography to Evaluate Pulmonary Vascular and RV Function During Exercise
  315. The Potential Cardiotoxic Effects of Exercise
  316. review of the current status of experimental models for Systems Biology research
  317. Exercise-induced pulmonary oedema in endurance triathletes
  318. Let's keep running… exercise, basic science and the knowledge gaps
  319. Effect of respiration on cardiac filling at rest and during exercise in Fontan patients: A clinical and computational modeling study
  320. Understanding the Mechanism of T-Wave Inversion in Athletes May Be Key to Best Management
  321. T-wave subtleties in screened athletes: sharpening the lead or whittling the pencil away?
  322. Reply to Sanchis-Gomar et al.—Undeniable Benefits of Exercise Should Not Preclude Inquiry Into the Mechanisms of Arrhythmias in Athletes
  323. Young Women With Abdominal Obesity Have Subclinical Myocardial Dysfunction
  324. Subepicardial delayed gadolinium enhancement in asymptomatic athletes: let sleeping dogs lie?
  325. Early repolarization patterns associated with increased arrhythmic risk are common in young non-Caucasian Australian males and not influenced by athletic status
  326. Relationship between Inflammatory Cytokines and Indices of Cardiac Dysfunction following Intense Endurance Exercise
  327. Response to Letters Regarding Article, “Can Intensive Exercise Harm the Heart? You Can Get Too Much of a Good Thing”
  328. Exercise-induced right ventricular dysfunction is associated with ventricular arrhythmias in endurance athletes
  329. Abnormal right ventricular relaxation in pulmonary hypertension
  330. Correction
  331. Right ventricular suction: an important determinant of cardiac performance
  332. Signs of RV overload on the athlete’s ECG
  333. Let's keep running… exercise, basic science and the knowledge gaps
  334. Physiologic and pathophysiologic changes in the right heart in highly trained athletes
  335. Is Exercise Good for the Right Ventricle? Concepts for Health and Disease
  336. Pulmonary Vascular and Right Ventricular Reserve in Patients With Normalized Resting Hemodynamics After Pulmonary Endarterectomy
  337. Right Precordial T-Wave Inversion in Healthy Endurance Athletes Can Be Explained by Lateral Displacement of the Cardiac Apex
  338. Exercise pathophysiology and sildenafil effects in chronic thromboembolic pulmonary hypertension
  339. Straining the RV to Predict the Future∗
  340. Acute effect of static exercise on the cardiovascular system: assessment by cardiovascular magnetic resonance
  341. Modest agreement in ECG interpretation limits the application of ECG screening in young athletes
  342. Defining the interaction between exercise and arrhythmogenic right ventricular cardiomyopathy
  343. Author response
  344. Exercise and Cardiovascular Risk in Patients With Hypertension
  345. The right ventricle following prolonged endurance exercise: are we overlooking the more important side of the heart? A meta-analysis
  346. Exercise blood pressure: clinical relevance and correct measurement
  347. Fluoroscopic Ring of Pannus within a Mechanic Mitral Valve: A Novel Sign of Calcified Pannus Infiltration
  348. Right Heart Structural and Functional Remodeling in Athletes
  349. Can Intensive Exercise Harm the Heart?: You Can Get Too Much of a Good Thing
  350. Can Intensive Exercise Harm the Heart?: The Benefits of Competitive Endurance Training for Cardiovascular Structure and Function
  351. The response of the pulmonary circulation and right ventricle to exercise: exercise-induced right ventricular dysfunction and structural remodeling in endurance athletes (2013 Grover Conference series)
  352. Right Ventricular Fatigue Developing during Endurance Exercise
  353. Comparison of Frequency of Significant Electrocardiographic Abnormalities in Endurance Versus Nonendurance Athletes
  354. Sildenafil Improves Exercise Hemodynamics in Fontan Patients
  355. Interaction between respiration and right versus left ventricular volumes at rest and during exercise: a real-time cardiac magnetic resonance study
  356. Right Ventricular Structure and Function During Exercise
  357. The Impact of Long-Term Endurance Sports on the Right Ventricle: Evidence for Exercise-Induced Arrhythmogenic RV Cardiomyopathy
  358. Transit of micro-bubbles through the pulmonary circulation of Thoroughbred horses during exercise
  359. Cardiac Imaging and Stress Testing Asymptomatic Athletes to Identify Those at Risk of Sudden Cardiac Death
  360. Atrial fibrillation in athletes and the interplay between exercise and health
  361. To assess exertional breathlessness you must exert the breathless
  362. Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
  363. The Seattle Criteria increase the specificity of preparticipation ECG screening among elite athletes
  364. Response to Letter Regarding Article, "Cardiac Magnetic Resonance Imaging: A New Gold Standard for Ventricular Volume Quantification During High-Intensity Exercise"
  365. Reduced Right Ventricular Myocardial Strain in the Elite Athlete May Not Be a Consequence of Myocardial Damage.“Cream Masquerades as Skimmed Milk”
  366. Exercise-Induced Arrhythmogenic Right Ventricular Cardiomyopathy
  367. Can Intense Endurance Exercise Cause Myocardial Damage and Fibrosis?
  368. Cardiac MRI: A New Gold Standard for Ventricular Volume Quantification During High-Intensity Exercise
  369. Ventricular arrhythmias associated with long-term endurance sports: what is the evidence?
  370. Targeted therapies in breast cancer: are heart and vessels also being targeted?
  371. The right heart in athletes
  372. The right heart in athletes
  373. The athlete's heart
  374. Exercise Strain Rate Imaging Demonstrates Normal Right Ventricular Contractile Reserve and Clarifies Ambiguous Resting Measures in Endurance Athletes
  375. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes
  376. Asymmetric collimation can significantly reduce patient radiation dose during pulmonary vein isolation†
  377. Should Pre-participation Cardiovascular Screening for Competitive Athletes be Introduced in Australia? A Timely Debate in a Sport-loving Nation
  378. Maximal oxygen consumption is best predicted by measures of cardiac size rather than function in healthy adults
  379. CardioPulse Articles
  380. Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation
  381. Disproportionate Exercise Load and Remodeling of the Athlete's Right Ventricle
  382. Long-term endurance sport is a risk factor for development of lone atrial flutter
  383. Pulmonary Vascular Resistance as Assessed by Bicycle Stress Echocardiography in Patients With Atrial Septal Defect Type Secundum
  384. Strenuous endurance exercise: is more better for everyone? Our genes won't tell us
  385. Clinical Consequences of Intense Endurance Exercise Must Include Assessment of the Right Ventricle
  386. Right ventricular function by strain echocardiography
  387. One- and Two-dimensional Estimation of Right and Left Ventricular Size and Function—Comparison with Cardiac Magnetic Resonance Imaging Volumetric Analysis
  388. Pulmonary transit of agitated contrast is associated with enhanced pulmonary vascular reserve and right ventricular function during exercise
  389. Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin
  390. Continuing Medical Education Program inEchocardiography
  391. Left Ventricular Torsion Parameters are Affected by Acute Changes in Load
  392. The echocardiographic assessment of the right ventricle: what to do in 2010?
  393. Left ventricular strain and strain rate: characterization of the effect of load in human subjects
  394. Three-dimensional cardiac rotational angiography: effective radiation dose and image quality implications
  395. The Fontan circulation: who controls cardiac output?
  396. Left Ventricular Untwisting Is an Important Determinant of Early Diastolic Function
  397. Athlete's Heart: The Potential for Multimodality Imaging to Address the Critical Remaining Questions
  398. Apical ballooning syndrome during treatment with a vascular endothelial growth factor receptor antagonist
  399. Biochemical and functional abnormalities of left and right ventricular function after ultra-endurance exercise
  400. Augmentation of Left Ventricular Torsion with Exercise is Attenuated with Age
  401. Reduced and delayed untwisting of the left ventricle in patients with hypertension and left ventricular hypertrophy: a study using two-dimensional speckle tracking imaging
  402. Effect of Heart Rate on Tissue Doppler Measures of Diastolic Function
  403. Exercise—Is it Possible to Have Too Much of a Good Thing?
  404. No Evidence of Sustained Myocardial Injury Following an Ironman Distance Triathlon